NCT05085769

Brief Summary

This study aimed to examine the effects of obesity and bariatric surgery on gut microbiota in a Turkish population, and to contribute to the literature by bringing multi-dimensional parameters including dietary intake, metabolic and inflammatory markers. This case-control study was conducted between June 2015 and August 2019. All participants were followed during the six-month period. Face-to-face interviews and physical examinations were held, and blood and fecal samples were collected at the baseline (M0) and at the end of 3 (M3) and 6 months (M6). Dietary intakes of subjects were assessed using 24-h dietary recall method in each interview and a detailed quantitative food frequency questionnaire that involved 85 food items. Subjects were recruited to the study as three groups: 15 patients who had bariatric surgery as study group, 8 morbidly obese participants who did not have bariatric surgery as control group-1 and 11 participants who were non-obese (lean (n=5) and pre-obese (n=6)) as control group-2. All subjects in the study group had sleeve gastrectomy. Subjects in control groups were selected as age and gender matched with the participants in the study group. Individuals were excluded if (a) they were under 19 or above 65 years old, (b) they had an acute or chronic inflammatory disease, (c) they were diagnosed with infectious diseases, cancer or alcohol addiction, (d) they used antibiotics in last 3 months before the screening.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2015

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2015

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2018

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2019

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

September 7, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

October 20, 2021

Completed
Last Updated

October 20, 2021

Status Verified

October 1, 2021

Enrollment Period

3.3 years

First QC Date

September 7, 2021

Last Update Submit

October 19, 2021

Conditions

Keywords

obesitybariatric surgerygut microbiomediet

Outcome Measures

Primary Outcomes (2)

  • Changes in gut microbial profiles of participants

    Changes in bacterial phyla and sub-phylum levels

    6 months

  • Changes in gut bacterial biodiversity of participants

    Changes in gut bacterial alpha and beta biodiversity of participants

    6 months

Secondary Outcomes (2)

  • Changes in dietary energy and nutrient intakes

    6 months

  • Changes in food intakes

    6 months

Other Outcomes (9)

  • Changes in body weight

    6 months

  • Changes in body mass index

    6 months

  • Changes in body fat and fat free mass

    6 months

  • +6 more other outcomes

Study Arms (3)

Study group

15 patients who had bariatric surgery

Procedure: Bariatric surgery

Control group-1

8 morbidly obese participants who did not have bariatric surgery

Control group-2

11 participants who were non-obese

Interventions

A procedure for morbidly obese patients whose body mass index (BMI) is higher than 40 kg/m2 or 35 kg/m2 and having comorbidities of obesity.

Study group

Eligibility Criteria

Age26 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Subjects were recruited to the study as three groups: 15 patients who had bariatric surgery as study group, 8 morbidly obese participants who did not have bariatric surgery as control group-1 and 11 participants who were non-obese (lean (n=5) and pre-obese (n=6)) as control group-2.

You may qualify if:

  • morbidly obese participants for study and control group-1
  • non-obese participants for control group-2

You may not qualify if:

  • they were under 19 or above 65 years old,
  • they had an acute or chronic inflammatory disease,
  • they were diagnosed with infectious diseases, cancer or alcohol addiction,
  • they used antibiotics in last 3 months before the screening.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Ozdemir A, Sarzhanov F, Dogruman-Al F, Gundogdu A, Nalbantoglu U, Yozgat A, Yildiz BD, Buyuktuncer Z. Exploring the complex interplay of Blastocystis, morbid obesity, and bariatric surgery on gut microbial dynamics. Microb Pathog. 2025 Mar;200:107306. doi: 10.1016/j.micpath.2025.107306. Epub 2025 Jan 15.

MeSH Terms

Conditions

Obesity

Interventions

Bariatric Surgery

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

BariatricsObesity ManagementTherapeuticsSurgical Procedures, Operative

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant

Study Record Dates

First Submitted

September 7, 2021

First Posted

October 20, 2021

Study Start

June 1, 2015

Primary Completion

September 1, 2018

Study Completion

August 1, 2019

Last Updated

October 20, 2021

Record last verified: 2021-10

Data Sharing

IPD Sharing
Will not share